To study the potential role of MT1-MMP and TIMP-2 in AKT activation we used human MCF-7 mammary carcinoma cells stably transfected with MT1-MMP under control by the tetracycline resistance transactivator (Tet-Off) [37]. Here, TIMP2 is linked to breast carcinoma.